1.  The Department may, to the extent that money is available, administer a program pursuant to 42 U.S.C. § 300ff-21 et seq. to provide therapeutics to treat certain persons who have been diagnosed with the human immunodeficiency virus and to prevent the serious deterioration of the health of such persons. The program may include the provision of subsidies and pharmaceutical services.

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

2.  The Director shall:

(a) Establish the criteria for eligibility for participation in the program administered pursuant to this section, which must be in accordance with the provisions of 42 U.S.C. § 300ff-21 et seq.; and

(b) Prescribe the manner in which the program will be administered and services will be provided.

3.  The Department may use any other program administered by the Department to facilitate the provision of subsidies and services pursuant to this section. If the Department uses another program to facilitate the provision of subsidies and services pursuant to this section, the Department shall not commingle the money available to carry out the provisions of this section and the money available to carry out the other program.

4.  Money available to carry out the provisions of this section must be accounted for separately by the Department. The Department shall use such money only to pay for or subsidize the cost of:

(a) Drugs approved by the United States Food and Drug Administration;

(b) Insurance premiums, deductibles, copayments, coinsurance or other cost-sharing obligations associated with private health insurance; and

(c) Services that improve access to, adherence to and monitoring of drug treatment.